Publications by authors named "Ronan Kelly"

Claim this Profile
L
Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studies.
William Roell, Jorge Alsina-Fernandez, Hongchang Qu, Tamer Coskun, Charles Benson, Ronan P Kelly

Mol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.
Joanna Palade, Eric Alsop, Nanyun Tang, Jerry Antone, Dorothy M Paredes, Ronan J Kelly

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating anatomical challenges of minimally invasive mitral valve replacement in a patient with severe scoliosis.
Henri Bartolozzi, Edward Bartolozzi, Darragh Rice, Ronan J Kelly, Mattia Glauber

J Surg Case Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scalable Membrane Enabled One-Pot Liquid-Phase Oligonucleotide Synthesis.
Ronan Kelly, Catalina Parga, Steven Ferguson

Org Process Res Dev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications.
Michal Harel, Nili Dahan, Coren Lahav, Eyal Jacob, Yehonatan Elon, Ronan J Kelly

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Gastric pH on the Pharmacokinetics of Atorvastatin and its Metabolites in Healthy Participants.
Bridget Louise Morse, Xiaosu Ma, Rong Liu, Shobha N Bhattachar, Clare Nicoll, Ronan Philip Kelly

Eur J Drug Metab Pharmacokinet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers.
Ronan J Kelly, Valsamo Anagnostou, Vincent K Lam, Ali H Zaidi

Clin Transl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related encephalitis after immune checkpoint inhibitor therapy.
Monica W Buckley, Aanika Balaji Warner, Julie Brahmer, Laura C Cappelli, William H Sharfman, Ronan J Kelly

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parenting and mental health in protracted refugee situations: a systematic review.
Qusai Khraisha, Nadeen Abujaber, Sadhbh Carpenter, Robert J Crossen, Johanna Kappenberg, Ronan Kelly

Compr Psychiatry· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy.
Fyza Y Shaikh, Seoho Lee, James R White, Yujie Zhao, Jacqueline T Ferri, Ronan J Kelly

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma.
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.
Susanna Hegewisch-Becker, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Ronan J Kelly

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sitravatinib combined with PD-1 blockade enhances cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma.
Ryan Sweeney, Ashten N Omstead, John T Fitzpatrick, Ping Zheng, Anastasia Gorbunova, Ronan J Kelly

Carcinogenesis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.
Ronan J Kelly, Blair V Landon, Ali H Zaidi, Dipika Singh, Jenna V Canzoniero

Nat Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Immunotherapy in Gastroesophageal Cancers-Advances, Challenges and Future Strategies.
Emer Lynch, Austin G Duffy, Ronan J Kelly

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brave new world-new and emerging treatments for gastric cancer.
Emer Lynch, Austin G Duffy, Ronan J Kelly

Chin Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creation of a versatile automated two-step purification system with increased throughput capacity for preclinical mAb material generation.
Anthony S Ransdell, Melora Reed, John Herrington, Paul Cain, Ronan M Kelly

Protein Expr Purif· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer.
Ronan J Kelly, Katherine Bever, Joseph Chao, Kristen K Ciombor, Cathy Eng

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Daniel Vt Catenacci, Yoon-Koo Kang, Hope E Uronis, Keun-Wook Lee, Matthew Ch Ng, Ronan J Kelly

Oncology (Williston Park)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma.
Emer Lynch, Austin G Duffy, Ronan J Kelly

Pharmaceuticals (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma.
Ali H Zaidi, Muhammad Yogi Pratama, Ashten N Omstead, Anastasia Gorbonova, Rubab Mansoor, Ronan J Kelly

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma.
Hirsch Matani, Divya Sahu, Michael Paskewicz, Anastasia Gorbunova, Ashten N Omstead, Ronan J Kelly

Biomark Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model.
Ashten N Omstead, Michael Paskewicz, Anastasia Gorbunova, Ping Zheng, Madison S Salvitti, Ronan J Kelly

Carcinogenesis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19.
Cindy Ke Zhou, Monica M Bennett, Carlos H Villa, Kendall P Hammonds, Yun Lu, Ronan J Kelly

PLoS One· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Texas Immuno-Oncology Biorepository, a statewide biospecimen collection and clinical informatics system to enable longitudinal tumor and immune profiling.
Ronan J Kelly, Timothy G Whitsett, G Jackson Snipes, Sheila M Dobin, Jennifer Finholt

Proc (Bayl Univ Med Cent)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis